Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| GLOBAL GEOPH | GGS | 7.79% |
| STAAR SURGIC | STAA | 6.23% |
| KAPSTONE PAP | KS | 6.14% |
| HORNBECK OFF | HOS | 5.99% |
| ANIKA THERAP | ANIK | 5.55% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Deckers Outdoor Corporation (DECK - Analyst Report) seems to be in an unfavorable position as the soft economic environment continues to take its toll on the performance of this designer, producer, and brand manager of innovative, niche footwear and accessories, as evident from its second-quarter 2012 bottom line results.
The company’s dismal performance compelled us to take a bearish stance on the stock, and therefore we went on to downgrade our recommendation to “Underperform” with a price target of $33.00. Earlier, we had a “Neutral” view on the stock.
Second Quarter Loss Widened
Deckers second-quarter 2012 loss of 53 cents a share fared better than the Zacks Consensus Estimate of loss of 59 cents but widened from a loss of 19 cents delivered in the year-ago quarter due to sluggishness in the European market on account of the ongoing economic crisis. International sales during the quarter dropped 14.7% to $61 million. UGG brand net sales fell marginally by 0.3%, whereas Teva brand net sales tumbled 15.4%.
Despite a 14% expected growth in the top line, management projects fiscal 2012 earnings to decline between 9% and 10%, and anticipates 1% growth in total revenue and a 31% decline in earnings per share for the third quarter.
Deckers, which competes with Wolverine World Wide Inc. (WWW - Snapshot Report) and Nike Inc. (NKE - Analyst Report), also forecasts a gross profit margin contraction of 250 basis points due to increase in costs of goods sold and higher closeout sales level for fiscal 2012.
Downhill Estimate Revision
Following Deckers’ second quarter results, the Zacks Consensus Estimates have been portraying a downward trend.
The Zacks Consensus Estimate for the third quarter of 2012 dropped by 5 cents to $1.07 per share in the last 60 days. For the fourth quarter, the Estimate fell 16 cents to $3.59. For fiscal 2012 and 2013, the Zacks Consensus Estimates slid 24 cents and 30 cents to $4.24 and $4.96, respectively, in the last 60 days.
Other Weaknesses
Deckers’ over-reliance on the UGG brand is a matter of concern. In the event of stagnation or decline of UGG sales growth, the company’s overall results will be affected adversely. This is because the percentage of contribution from the company’s other brands are too small to offset any slowdown in UGG sales.
Due to high exposure to international markets, Deckers remains prone to currency fluctuations. The weakening of foreign currencies against the U.S. dollar may require the company to either raise prices or contract profit margins in locations outside the U.S. An increase in price may have an adverse impact on the demand for the products.
Closing Comment
An erratic consumer behavior and a sluggish economic recovery still remain matters of concern. The above analysis supports our unbiased view, and advocates our bearish stand on the stock, which is well defined through our Zacks #5 Rank that translates into a short-term “Strong Sell” rating.
Get the full Analyst Report on NKE - FREE
Get the full Analyst Report on DECK - FREE
Get the full Snapshot Report on WWW - FREE